MHMohammad A. Haidar

Mohammad A. Haidar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohammad A. Haidar has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Armand Glassman

    Hematopathology Program, University of Texas M.D. Anderson Cancer Center, Houston, Texas

    1 shared publication
  • Carlos E. Bueso-Ramos

    Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

    1 shared publication
  • Carlos E. Bueso‐Ramos

    Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

    1 shared publication
  • Hagop M. Kantarjian

    Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

    1 shared publication
  • Hamid El‐Hajj

    Hematopathology Program, University of Texas M.D. Anderson Cancer Center, Houston, Texas

    1 shared publication
  • Hemantkumar S. Patel

    Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA

    1 shared publication

Latest Publications

  • Frequent deletions at 12q14.3 chromosomal locus in adult acute lymphoblastic leukemia

    by Hemantkumar S. Patel, Hagop M. Kantarjian, Carlos E. Bueso‐Ramos, L. Jeffrey Medeiros, Mohammad A. Haidar

    Cytogenetic abnormalities at the 12q12‐q14 chromosomal locus are rarely detected in acute lymphoblastic leukemia (ALL). To examine submicroscopic deletions at this locus, we analyzed 78 adult precursor B‐ and T‐cell ALL cases [27 with Philadelphia chromosome (Ph)–negative B‐cell ALL, 20 with Ph‐negative B‐cell ALL with expression of one or two myeloid markers, 18 with Ph‐positive B‐cell ALL, and 13 with T‐cell ALL] using a panel of 13 microsatellite (MST) markers that span the 12q12–q14.3 region. The status of MST markers was evaluated by use of polymerase chain reaction performed with fluorescence‐labeled primers and automated fragment analysis. The MST marker analyses showed submicroscopic deletions at the 12q14.3 locus in 20 of the 78 ALL cases (26%). The frequency of deletions was highest in Ph‐negative B‐cell ALL (13 of 27, 48%) compared with that in Ph‐negative B‐cell ALL with expression of myeloid markers (4 of 20, 20%), Ph‐positive B‐cell ALL (2 of 18, 11%), and T‐cell ALL (1 of 13, 8%). Deletion frequencies of MST markers along the 12q12–q14.3 locus suggest that the targeted gene of deletion is located within a 170‐kb region bordered by the markers D12S1504 (approximately 65 kb upstream of HMGA2) and D12S1509 (in intron 3 of HMGA2) at the 12q14.3 locus. These submicroscopic deletions at the 12q14.3 locus may play a role in the pathogenesis of ALL, particularly in Ph‐negative precursor B‐cell ALL.


  • Open Access

    Expression profile of MDM‐2 proteins in chronic lymphocytic leukemia and their clinical relevance

    by Mohammad A. Haidar, Hamid El‐Hajj, Carlos E. Bueso‐Ramos, Taghi Manshouri, Armand Glassman, Michael J. Keating, Maher Albitar